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ABSTRACT 
 
Background: Leishmaniasis is a worldwide disease prevalent in tropical and sub tropical coun-
tries. Many attempts have been made and different strategies have been approached to develop a 
potent vaccine against Leishmania. DNA immunisation is a method, which is shown to be effec-
tive in Leishmania vaccination. Leishmania Soluble Antigen (SLA) has also recently been used 
Leishmania vaccination.  
Methods: The immunity generated by SLA and  L. mexicana gp63 cDNA was compared in 
groups of 6 mice, which were statistically analysed by student t- test with the P-value of 0.05. 
SLA was administered by two different methods; intramuscular injection and injection of den-
dritic cells (DCs) loaded with SLA. L. mexicana gp63 cDNA was administered by the gene gun.  
Results: Immunisation of BALB/c mice with L. mexicana gp63 resulted in high levels of Th1-
type immune response and cytotoxic T lymphocytes (CTL) activity, which were accompanied 
with protection induced by the immunisation against  L. mexicana infection. In contrast, 
administration of SLA, produced a mixed Th1/Th2-type immune responses as well as a high 
level of CTL activity but did not protect mice from the infection.  
Conclusion:  The results indicate higher protection by DNA immunisation using L. mexicana 
gp63 cDNA compared to SLA, which is accompanied by a high level of Th1 immune response. 
However, the CTL activity does not necessarily correlate with the protection induced by the vac-
cine. Also, gene gun immunisation is a potential approach in Leishmania vaccination. These find-
ings would be helpful in opening new windows in Leishmania vaccine research. 
 
Keywords: Leishmania mexicana, Gene gun, gp63, Leishmania Soluble Antigen, BALB/c 
 
 
*Corresponding author: Tel: 0811-4227350, Fax: 0811-4227475, E-mail: hrezvan@gmail.com. 
 
 
 
 
 
 
 
Iranian Society of Parasitology 
http:// isp.tums.ac.ir 
 
Iranian J Parasitol 
 
Open access Journal at 
http:// ijpa.tums.ac.ir 
 
Tehran University of Medical 
Sciences Publication 
http:// tums.ac.ir 
 
   Rezvan  et al. : Leishmania mexicana Gp63 cDNA … 
 
61 
Introduction  
 
eishmania  is an obligate intracellular 
parasite of the macrophage-dendritic 
cell lineage. Although the first species 
of this parasite was known more than 100 
years ago (1), construction of an effective 
vaccine against it has not yet been achieved 
(2). As  Leishmania  lives intracellularly in 
macrophages, the humoral immune system 
cannot be of great help in immunity and 
therefore the vaccine-developing strategies 
must involve the cellular immunity, which 
has a bias towards the Th1 immune pathway. 
Due to the complexity of the mechanisms 
involved in immunity to  Leishmania, 
different vaccine strategies have been 
proposed (3).  
DNA vaccination is the latest method of 
immunisation implicated in  Leishmania 
vaccination, shown to have potential to in-
duce immunity to Leishmania in mice (4). In 
this method, DNA sequences that encode a 
Leishmania  antigen are spliced into an 
expression vector, which is administered to 
the host cells to promote the production of 
Leishmania protein (5, 6). Leishmania zinc-
metaloproteinase called gp63 is a character-
ized protein of  Leishmania  species. The 
immunogenicity of  Leishmania  gp63 has 
been shown in different studies by several 
research groups (7-9).  
The immunity induced by soluble Leishma-
nia antigen (SLA) has also generated interest 
among Leishmania researchers. L. donovani 
promastigote soluble antigens were encapsu-
lated in non-phosphatidylcholine liposomes 
derived from E. coli lipids elicited a protec-
tive immune response against experimental 
visceral leishmaniasis (10). Immunization 
with soluble Leishmania antigen in IFA plus 
Ad5IL-12 vector induced protection in 
BALB/c mice against  L. major infection 
(11). 
Dendritic cells, as professional antigen pre-
senting cells, play a crucial role in immunity 
to Leishmania. There is a possible role for 
subsets of DCs in directing the immune re-
sponse towards either Th1 or Th2 following 
the encounter of an infectious agent, which 
may determine whether the host will resist or 
succumb to that infection (12).  
Loading DCs with anti-tumor antigens pro-
tected mice from tumor growth (13). In 
Leishmania  vaccination the potency and 
effectiveness of DC-based vaccines has been 
shown in both immunotherapy and 
chemotherapy (12, 14, 15). The cytokine 
profile of mice after DC-based vaccination 
has demonstrated a shift toward a Th1-type 
response in which IL-12 has a critical role 
(15) and because DCs exposed to L. major 
readily produce IL-12, it may further in-
crease the feasibility of using the DC-based 
vaccines (16).  
In the present study, protection induced by 
L. mexicana gp63 cDNA, SLA containing 
the gp63, and DCs loaded with L. mexicana 
gp63 in Leishmania sensitive BALB/c mice 
against  L. mexicana was investigated. In 
addition, the CTL activity and antibody re-
sponses rendered by  L. mexicana gp63 
cDNA and SLA were studied.  
 
Materials and Methods 
 
Animals 
BALB/c mice were purchased from the 
Harlan Olac (Oxon, UK) and bred at the 
Nottingham Trent University animal house. 
All animals were housed in accordance with 
the Home Office Codes of Practice for the 
housing and care of animals. 
 
Leishmania parasites, cells and infection 
L. mexicana promastigotes strain M379 were 
kindly gifted by Dr. Varley, the London 
School of Hygiene and Tropical Medicine 
(LSHTM), and cultured in Schneider media 
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(Sigma, US) supplemented with 10% FCS at 
25 ºC as described by (17).  
Three groups of 6 mice were routinely in-
fected, unless otherwise indicated, by 
intradermal inoculation of 1 · 10
6 promas-
tigotes into a shaved area of the back region 
about 1 cm from the tail base and were 
monitored at 3- to 4-day intervals. Mice 
were killed when lesion size exceeded 1 
cm2. For all experiments, student t- test was 
used to statistically analyze the data. The P-
value estimated by t-test between groups test 
and control was 0.05.  
The CT26 cell line (N-methylurethane-in-
duced BALB⁄ c murine colon carcinoma) 
was a kind gift from Prof. Ian Hart (St Tho-
mas Hospital). Cells were cultured and 
maintained in Dulbecco’s modified Eagle's 
medium (DMEM)+10% foetal calf serum 
(FCS) (Bio Whittaker, Europe). 
 
Generation of DCs 
BM-DC was generated as described by 
Inaba and coworkers with some modifica-
tions (18). Briefly, hind limbs of naïve 
BALB/c mice were collected and all muscle 
was removed using scalpel and tweezers. 
After cutting the ends of the bone, bone-
marrow cells were flushed out and har-
vested. Then the bone marrow cells 
centrifuged and resuspended in 1ml BM-DC 
media, and plated at 1·10
6 cells per well/ml 
with 100ng/ml of mGM-CSF. The cells were 
then incubated overnight at 37
○ C, 5% CO2. 
On day 2 and day 4, non-adherent cells were 
washed out by gently replacing 700µl/well 
of media with fresh DC media containing 
GM-CSF. On day 6, BM-DC were repeated 
and split into two groups. The first group 
(test) were pulsed with 10µg/ml SLA and 
the second group was used as control. Con-
trol and test groups were pulsed 4-6hrs later 
by 1µg/ml LPS to induce maturation. The 
following day, BM-DCs were washed in se-
rum free RPMI 1640 media, counted and 
injected intradermally at 2·10
6 per mouse.  
 
FACS Analysis  
5·10
5 per tube DCs were harvested for 
FACS analysis. Cells were washed twice in 
PBS + 0.1%BSA + 0.02%NaN3. Rat anti-
mouse CD80, Macrophage/Monocyte 
marker (F4/80), DEC205, I-A (murine class 
II) and CD45, and hamster anti-mouse 
CD11c monoclonal antibodies were added. 
Appropriate isotype controls were used in 
each experiment. The cells were incubated 
on ice for 30 minutes with primary antibod-
ies. Cells were then washed twice in PBS + 
0.1%BSA + 0.02%NaN3  and incubated for 
30 minutes on ice with FITC coupled goat 
anti-rat IgG or goat anti-hamster IgG as 
secondary antibodies as appropriate. Finally 
the cells were washed in PBS + 0.1%BSA + 
0.02%NaN3 and resuspended in 500µl of 
sheath fluid, and then the FACS analysis 
was performed. 
 
Preparation of SLA 
The L. mexicana SLA was prepared accord-
ing to what previously described by Dumon-
teil (9). Briefly, late log phase L. mexicana 
promastigotes were washed 4 times in PBS 
and then the parasites were resuspended in 
100mM Tris buffer, pH 7.3 containing 1mM 
EDTA, 0.5mM PMSF (Sigma, US) and 
2.5g/ml Leupeptin (Sigma, US). The para-
sites were lysed by sonication and the lysate 
was centrifuged at 13000rpm  for 20 min. 
The supernatant was centrifuged again for 4 
h at 39,000rpm, and then was dialyzed 
against 5 litters of cold PBS overnight with 
continuous agitation and several changes of 
the PBS. The lysate was sterilized by pass-
ing through 22µm filters (Sartorius, US).  
 
Coating of gold particles by DNA 
DNA was coated onto 1.0 Micron gold parti-
cles (Biorad, Hemel Hempstead, Hertford-
shire, UK) using manufacturers’ instruction Rezvan  et al. : Leishmania mexicana Gp63 cDNA … 
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and administered by Helios Gene Gun (Bio-
rad, Hemel Hempstead, Hertfordshire, UK). 
Briefly, 200 µl of spermidine was added to 
16.6 μg of gold followed by sonication. 200 
µl of 1M calcium chloride was added to the 
DNA-Spermidine solution followed by 
incubation at room temperature for 10 min-
utes. Tubes were centrifuged at 13,000 rpm 
for 1 min and gold particles resuspended in 
dry ethanol (Sigma, US). After repeating the 
above step 2 more times, particles were 
resuspended in 0.025mg/ml of PVP in dry 
ethanol. During these steps, the plastic tub-
ing was dried using nitrogen for 15-20 min-
utes using nitrogen gas. The resuspended 
gold particles were loaded into the dried tub-
ing using a syringe and the tubing was 
placed on the roller/dryer (Biorad, Hemel 
Hempstead, Hertfordshire, UK) followed by 
incubation for 15 minutes. The PVP-dry 
ethanol was gently removed using the sy-
ringe and the tube was rotated on the roller 
along with nitrogen gas being passed 
through it for 5 minutes. Bullets were then 
cut using guillotine and stored at 4ºC until 
used for immunization. 
 
DNA construct 
To assess the immunogenicity of  L. mexi-
cana gp63, the  L. mexicana gp63 gene 
cloned into VR1012 plasmid vector, a gift 
from Dr Dumonteil Laboratorio de Parasi-
tología Yucatan Mexico. 
oliver@tunku.uady.mx (9), and used in the 
investigation. The DNA was bulked up by 
transformation of  E. coli followed by 
purification using Quia-gen EndoFree plas-
mid purification Maxi Prep Kits and all the 
products were evaluated by UV spectropho-
tometer at 260 and 280nm. The ratio 
OD260/OD280 was always more than 1.7. 
The construct was also sequenced by MWG-
Biotech using 5’-
ACATCCTCACCGACGAGAAG-3’, 5’-
CTTGAAGTCGCCACAGATCA-3’, 5’-
GCTGCAACAGCTTGGAGTATC-3’ and 
5’-GATACTACACCGCCCTGTGC-3’ 
primers and checked for mismatches against 
the sequence obtained from the gene bank. 
 
CTL Assay 
LPS Blast  
Between 2-3 days prior to the removal of 
spleens from immunized mice, naïve spleno-
cytes were cultured at 1.5·10
6  cells/ml in 
40ml T cell media containing 25µg/ml LPS 
and 7µg/ml dextran sulphate in a T75 culture 
flask and incubated at 37
0C, 5%CO2. On the 
day of isolation of immunized mice spleno-
cytes, LPS treated naïve splenocytes were 
irradiated at 3000rads for 4 minutes. Cells 
were washed and pulsed with 100µg/ml of 
relevant or irrelevant peptides separately for 
at least 1 hour. Cells were then washed, 
counted and added to culture plates contain-
ing splenocytes from immunized mice at 5 · 
10
5/well.  
 
In vitro generation of CTLs 
One week after the last immunization, 
spleens were harvested from the immunized 
mice and single cell suspensions were pre-
pared in sterile conditions. Cells were 
flushed out from the spleens by serum-free 
RPMI1640. All cells were centrifuged at 
1500rpm for 3 minutes and resuspended in 
CTL media (RPMI 1640 supplemented with 
1% L-glutamine, 10%FCS, 20mM HEPES 
buffer, 50mM 2-Mercapto Ethanol, 50U/ml 
penicillin, 50mg streptomycin and 0.25mg/ml 
fungizone). The cells were counted using 
white cell counting fluid (0.6% acetic acid in 
distilled water) and 0.1%Trypan Blue, and 
plated in a 24 well plate at 2.5·10
6 
cells/500ml/well. 5·10
5 /500ml irradiated and 
peptide pulsed LPS blasts were added to the 
splenocytes to make a final volume of 1ml in 
each well of 24 well plate. Supernatants 
were collected usually on day 3 and 5 for 
cytokine testing. In certain experiments SLA Iranian J Parasitol: Vol. 6, No.4, 2011, pp.60-75 
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was used instead of peptide to stimulate CTL 
activity in vitro. 
 
Chromium Release Cytotoxicity Assay 
On day 5 of in vitro stimulation, splenocytes 
were harvested, washed twice in serum free 
medium, counted and resuspended in CTL 
media and used as the effectoer cells. CT-26 
or CDs were also harvested, washed and la-
beled with chromium-51 (Amersham, UK) 
followed by 1h incubation at 37°C. The 
CT26 labeled cells were then pulsed with 
relevant and irrelevant peptides separately 
and incubated for 1 hour at 37°C. For DCs, 
the cells were split into two groups. One 
group was loaded with SLA and the other 
was used as control. A standard 4 hour Cr 
release assay was performed and the specific 
cytotoxicity was determined using the 
following formulae. 
 
percentagecytotoxicity=
(experimentalrelease − spontaneous release)
(maximum release -spontaneous release )
× 100  
 
Detection of anti-Leishmania IgG2a and 
 IgG1 isotype antibodies  
After immunization, mice were regularly 
bled for 7 times at a week interval starting a 
week after the last immunization. The blood 
samples were harvested and span at 200rpm 
for 10 min. The serum was collected and 
stored at -20 until tested for specific immu-
noglobulin IgG1 and IgG2a using ELISA. 
Serum samples from 9 naïve mice were used 
for control.  L. mexicana Soluble Antigen 
(SLA) 1µg/well was coated on the flat bot-
tom 96-well plates (Biorad, Hemel Hemp-
stead, Hertfordshire, UK) and incubated 
overnight at room temp. After 4 times wash 
with PBS, 1:100 dilution of the serum sam-
ples in dilution reagent (1% BSA, 0.05% 
Tween 20 in 20mM Trizma base, 150mM 
NaCl, pH 7.2-7.4) was added in duplicate 
followed by 2h incubation at room temp and 
4 times washes with PBS.  The plates were 
blocked with block buffer (1% BSA, 5% su-
crose in PBS with 0.05 NaN3) for 1hr. And 
then washed 4 times washes with PBS. Rab-
bit anti-mouse IgG1 or IgG2a (Serotech, 
UK) was added at 1:1000 followed by 1hour 
incubation at room temp and 4 times washes. 
HRP conjugated goat anti-rabbit antibody at 
1:1000 dilution was added and the plates 
were stored at room temp for 1h followed by 
4 times washes. 50µl of HRP substrate 
(DAKO, US) was added and kept at room 
temp for 20minutes for reaction develop-
ment. 2.5M H2SO4 was added to stop the 
reaction and the OD was measured at 570 
nm by spectrophotometer.  
 
Results 
 
Protection induced by L. mexicana gp63 
cDNA 
The gene gun was used in this study to 
immunize BALB/c mice with  L. mexicana 
gp63 cDNA. 1 m g of  L. mexicana gp63 
cDNA (VR1012) coated on gold particles 
(see Materials & Methods) was administered 
by gene gun into a shaved area of the abdo-
men. A control group of 3 mice was 
administered with gold particles coated with 
empty plasmid by the gene gun. The mice 
were immunized twice two weeks apart and 
the immunized mice were monitored regu-
larly followed by challenge with the parasite. 
Results indicated a significant protection in-
duced by immunization with 1µg  L. mexi-
cana gp63 cDNA using the gene gun; 66% 
(4 out of 6) of the immunized mice remained 
free of lesion (Fig. 1). 
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Protection induced by SLA + IFA 
To investigate the ability of SLA to protect 
the animals from Leishmania, a series of ex-
periments were performed using test and 
control groups of  Leishmania  sensitive 
BALB/c mice.  The test group was injected 
with 100µg of  L. mexicana SLA admixed 
with the same volume of IFA as adjuvant 
and the control group was injected with 
PBS. The results showed that two S.C. injec-
tions of SLA+IFA did not significantly 
decrease the size of the Leishmania lesion 
compared to controls (Fig. 2). 
  
Protection induced by Dendritic Cells (DC) 
loaded with SLA  
Immunity rendered by id inoculation of den-
dritic cells loaded with SLA against 
Leishmania was investigated. Bone-marrow 
cells were obtained from BALB/c mouse 
Femur and Tibia, and cultured with GM-
CSF for 6 days with gentle washes every 
two days (see materials and methods). On 
day 6, DCs were replanted at 1·10
6/ml and 
split into two groups. One group (test) was 
treated with the SLA at a concentration of 
10-15µg/ml and after 4-6 hours pulsed with 
1µg/ml LPS to mature. The second group of 
DCs (control) was only pulsed with LPS. On 
day 7, DCs were injected at 2·10
6 per mouse 
into groups of BALB/c mice. A third group 
of BALB/c mice were also injected with 
PBS and used as an additional control. DCs 
phenotype was determined with a number of 
Abs and FACS analyses (Fig. 3). Mice were 
immunized twice at two weeks interval and 
then were challenged with 2 · 10
6  L. mexi-
cana promastigotes. No significant protec-
tion was observed (Fig.4). 
 
CTL activity induced by immunization with 
gp63 cDNA construct 
To evaluate the role of cytotoxic T cells in 
immunity to  Leishmania, a standard 4 h 
cytotoxicity assay was to assess the ability of 
L. mexicana gp63 cDNA to generate specific 
cytotoxic T lymphocytes. BALB/c mice 
were immunized twice at two weeks interval 
with L. mexicana gp63 cDNA by gene gun. 
Mice were sacrificed two weeks following 
the 2nd immunization and spleens were col-
lected. Splenocytes were harvested and cul-
tured in vitro for 5 days together with blasts 
cells pulsed with LPS and SLA. On day 5, 
the splenocyte cells were used as effectors in 
cytotoxicity assays against CT26 tumor cells 
transfected with L. mexicana gp63 (Materi-
als and Methods section). 
The results clearly revealed that immuniza-
tion of mice with L. mexicana gp63 cDNA 
induces specific CTL activity against CT26 
tumor cells expressing L. mexicana gp63 and 
DCs loaded with SLA as targets (Fig. 5). 
The in vitro restimulation of CTLs by SLA 
loaded blast cells was crucial. It was shown 
that removing the in vitro restimulation of 
the splenocytes highly prevented the genera-
tion of CTL activity in immunized mice and 
levels was comparable with that of naïve 
mouse splenocytes restimulated in vitro by 
blast cells loaded with SLA. In vitro deple-
tion of CD8+ T cells by anti CD8 Ab and 
complement on day 5 significantly removed 
the CTL activity suggesting an effector role 
of CD8+ T cells in the CTL activity. 
 
CTL activity induced by SLA (SLA + IFA 
& DCs pulsed with SLA) 
The potency of SLA in inducing CTL activ-
ity was evaluated in BALB/c mice injected 
with SLA + IFA or DCs loaded with SLA. 
Mice were either subcutaneously injected 
with 100µg per mouse of SLA mixed with 
the same volume of IFA or intradermally 
immunized with 2 10
6 per mouse matured 
DCs loaded with SLA at the left flank. One 
injection of SLA + IFA or SLA loaded ma-
tured DC induced high level of CTL activity, 
when tested against DCs loaded with SLA in 
cytotoxicity assay (Fig. 6). 
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Antibody responses to Leishmania vaccines 
To study the direction of immune response 
raised by the vaccines, in a set of experi-
ments, five groups of six female BALB/c 
mice were used. The first group was immu-
nized with 1µg L. mexicana gp63 construct 
(VR1012) using gene gun. The second group 
was immunized with empty plasmid vector 
(VR1012) by gene gun. The third group was 
immunized S.C. with 100µg SLA admixed 
with the same volume of IFA. The forth 
group was injected S.C. with PBS. The 
immunization was carried out on day 0 and 
14, and one week after the second 
immunization, the mice were bled once a 
week regularly. Serum was separated and 
stored at -20 for antibody typing by ELISA 
to determine the level of anti-Leishmania 
IgG2a and IgG1 isotype antibodies.  
The results clearly demonstrated a sharp in-
crease of IgG2a in mice immunized with L. 
mexicana gp63 construct by gene gun as 
early as 7 days after the immunization, 
which slightly decreased afterward and re-
mained at that level during the course of ex-
periment. The results also showed that the 
gene gun immunization induced an increase 
in the level of IgG1 after day 14 similar to 
that obtained by immunization with the 
empty vector. Immunization of mice with 
SLA+IFA resulted in high levels of IgG1. 
The level of IgG2a induced by immunization 
with SLA+IFA was lower than that of IgG1 
during the course of study (Fig. 7).  
 
Antibody responses in mice immunized with 
DCs pulsed with SLA 
To determine the “direction” of the immune 
system following immunization with of DCs 
pulsed with SLA, groups of 6 BALB/c mice 
were either immunized I.D. with 2 10
6 
DCs loaded with SLA,or control DCs or 
PBS. DCs were prepared from bone marrow 
cells and loaded with10µg/ml SLA. One 
µg/ml LPS was also added to compete DC 
maturation (see materials and methods). 
Two weeks after the second immunization, 
all mice were bled to determine the level of 
mouse IgG, and IgG1 and IgG2a isotypes. 
The results clearly showed significant in-
crease in levels of total IgG, IgG1 and IgG2a 
in test groups compared with controls (Fig. 
8) indicating a rise of both Th1 and Th2-type 
antibody response in the immunized mice.
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Fig. 1: Gene gun immunisation with L. mexicana gp63 cDNA. 1µg per mouse of L. mexicana gp63 plasmid DNA 
(VR1012) coated on gold particles was introduced to abdomen skin of BALB/c mice by gene gun on day 0 and 14. 
The control group was given 1µg empty vector coated on gold particles. The mice were challenged with 2·10
6 log-
phase L. mexicana promastigote on day 28, and were monitored regularly. The graph represents 3 independent 
experiments. Bars represent the standard deviation n=6 
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Protection of L.mex SLA
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Fig. 2: Protection induced by SLA admixed with IFA in BALB/c mice. Two groups of 6 BALB/c mice 
were immunized S.C. with 100µg+IFA or PBS twice at 2 weeks interval. Meanwhile controls were in-
jected with PBS. Two weeks later mice were challenged with 2·10
6 L. mexicana promastigotes. The mice 
were monitored regularly and average of the surface of the lesions was measured. Student t test was used 
to statistically analyze the data. The graph represents 3 independent experiments. Bars represent the stan-
dard deviation n=6 
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Fig. 3: Protection induced by DCs loaded with SLA in BALB/c mice. Bone-marrow cells derived from 
BALB/c mice were cultured with GM-CSF for 7 days. One day before immunization, they were loaded 
with 10-15µg/ml SLA and pulsed with LPS 1µg/ml (see materials and methods). On day 7 DCs were 
phenotyped and then, 2·10
6 per mouse of each DC preparation was administered in a group of 6 BALB/c 
mice intradermally twice at two weeks interval. A control group of 3 mice were injected with PBS. The 
mice were challenged with 2·10
6 L. mexicana log phase promastigotes two weeks after the last immuniza-
tion and were monitored regularly. Student t-test was used to analyze the data. The graph represents 3 
independent experiments. Bars represent the standard deviation n=6 
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Fig. 4: CTL activity induced by gene gun immunisation using L. mexicana gp63 cDNA. BALB/c mice 
were immunized twice with L. mexicana gp63 using the gene gun twice; on day 0 and 14. On day 28 mice 
were sacrificed and the splenocytes were cultured in vitro with blast cells pulsed with LPS and SLA for 5 
days. On day 5 the cells were used as effector in standard cytotoxicity assay. A: DNA immunized mice 
restimulated with blast cells+SLA tested against CT26 L. mexicana gp63 cells. B: DNA immunized mice 
restimulated with blast cells+SLA tested against DCs pulsed with SLA C: naive mice restimulated with 
blast cells+SLA tested against CT26 L. mexicana gp63 cells. D: DNA immunized mice restimulated with 
blast cells+PBS tested against CT26 L. mexicana gp63 cells. The results represent 8 mice in 4 independent 
experiments 
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Fig. 5: CTL activity in mice immunised with SLA+IFA or DCs pulsed with SLA. BALB/c mice were 
injected S.C. with 100µg of SLA admixed with the same volume of IFA or immunized I.D. with 2·10
6 
DCs loaded with SLA per mouse. After two weeks the mice were sacrificed and their splenocytes were 
cultured in vitro for 5 days together with blast cells pulsed with LPS and SLA. On day 5 they were used as 
effector cells in a cytotoxicity assay against DCs pulsed with SLA 
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Fig. 6: Th1/Th2 direction of immune response in mice immunized with DNA or SLA. BALB/c mice 
were immunized with L. mexicana gp63 cDNA using the gene gun or injected S.C. with 100µg/mouse 
SLA mixed with the same volume of IFA. A control group of mice was immunized with the empty vector. 
An additional control group was also injected with PBS. All groups of mice were immunized twice at two 
week interval. After two immunizations, blood samples were collected every 7 days and ELISA was 
implicated to determine IgG2a and IgG1 isotype antibodies against SLA 
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Fig. 7: Ab responses in mice immunised with DCs loaded with SLA. Groups of 6 BALB/c mice were 
immunised S.C. either with 2
¿
10
6/mouse DCs alone or pulsed with SLA (see materials and meethods) 
on day 0 and day 14. On day 28 serum samples were collected and analysed by ELISA to determine the 
level of IgG, IgG1 and IgG1a. Data were analysed by student t-test. *  P> 0.05, **  P>0.01, ***  P>0.001 
 
Discussion 
 
Protection induced by L. mexicana gp63 or 
SLA 
DNA immunization is a method that has re-
cently been used in Leishmania vaccination. 
Different studies using different genes have 
shown the potency of this method in generat-
ing immunity to Leishmania (19, 20). Gp63 
is an immunogenic protein in  Leishmania 
parasites. It has been shown that administra-
tion of DNA encoding Leishmania gp63 pro-
tein can generate immunity and partially 
protect BALB/c mice from the infection (9, 
21). Gene gun immunization is a new ap-
proach recently been implicated in Leishma-
nia DNA immunization (22).  
The immunity induced by Soluble Leishma-
nia  Antigen has also generated interest 
among Leishmania researchers. In a study by 
Sharma (10) L. donovani promastigote solu-
ble antigens were encapsulated in non-phos-
phatidylcholine liposomes derived from  E. 
coli lipids elicited a protective immune re-
sponse against experimental visceral 
leishmaniasis. In another study, Immuniza-
tion with soluble Leishmania antigen in IFA 
plus Ad5IL-12 vector induced protection in 
BALB/c mice against  L. major infection 
(11). 
Here we compared the protection induced L. 
mexicana gp63 cDNA construct to that in-
duced by  L. mexicana soluble antigen 
containing  L. mexicana gp63 protein in a 
protection investigation in BALB/c mouse 
model. For administration of the DNA, 1µg 
of the  L. mexicana (VR1012) construct 
coated on gold particles was administered 
I.D. by gene gun. It was shown that gene 
gun immunization significantly protected 
mice from Leishmania infection, where 66% 
of immunized mice were free of lesions. The 
immunogenicity of SLA was examined in 
two modes of immunization. In the first ap-
proach, two injections of BALB/c mice with 
100µg/mouse of SLA mixed with 
100µg/mouse of IFA induced reduction in 
the size of lesions but did not significantly 
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prevented L. mexicana infection. However, 
administration of SLA induced levels of Th1 
and Th2 immune responses indicating the 
existence of immunogenic proteins in this 
preparation, which provokes immunity to 
Leishmania. Therefore, the identification of 
these immunogenic proteins and using them 
in potential vaccines as well as developing 
new methods for vaccine administration to 
enhance immunogenicity are future areas for 
Leishmania vaccine investigation. 
The second approach tested was the applica-
tion of DCs loaded with SLA. DCs are 
shown to be a potent adjuvant in Leishmania 
vaccination (16) and their potency in the 
generation of immunity to intracellular 
pathogens is dependent on the production of 
IL-12, which results in shifting the immune 
response toward Th1-type. It has been 
shown that the protective potential of DCs 
pulsed with a given Leishmania Ag corre-
lated with the level of their IL-12 expression 
(15). In a similar study, animals receiving 
DCs pulsed with L. donovoni soluble antigen 
either before or following infection had 1-3 
log lower parasite burdens as well as 
enhancement of the parasite-specific IFN-γ 
response. When SLA pulsed DCs were 
transfected with the IL-12 gene, the number 
of live parasites in the liver of vaccinated 
mice was further reduced and the 
parasitological response was associated with 
a nearly normal liver histology (12).  
Our results showed that immunization with 
DCs pulsed with SLA obtained from  L. 
mexicana did not protect BALB/c mice from 
Leishmania infection. This was in contrast 
with the results obtained by Moll in which 
DCs pulsed by SLA protected BALB/c mice 
from  L. major infection (16). The discrep-
ancy could be due to the difference between 
the species of  Leishmania  used. However, 
other results showed that DCs pulsed with 
SLA were potent in generating CTL activity 
and inducing a mixed Th1/Th2 immune re-
sponse. Further studies are required to clar-
ify the role of these immune responses in 
protection against the infection. 
 
CTL activity induced by L. mexicana gp63 
and SLA 
The role of CD8+ T cells in immunity to 
Leishmania  parasites is not yet fully 
established. There are studies demonstrating 
that  Leishmania  patients show high 
proportions of Leishmania-reactive CD8+ T 
cells (23) and it is thought that that CD8+ T 
cells help raise immunity to Leishmania in 
two different ways. These cells release a 
large amount of IFN-γ that in turn promotes 
a Th1 immune response to activate 
macrophages against the parasite. Also, 
activated CD8+T cells can kill macrophages, 
which are invaded by the parasite (see 
chapter 1) and it has been shown that DNA 
and DC-based vaccines elicit CD8+ immune 
response (24, 25). 
In the present study, the role of CTL T cells 
in the immunity induced L. mexicana gp63 
and SLA was investigated. The results re-
vealed that immunization of mice with  L. 
mexicana gp63 presented significant CTL 
activity in BALB/c mice tested against CT26 
tumor cell transfected with the relevant gene. 
Similar results were also obtained when DCs 
were transfected with  L. mexicana gp63 
cDNA and used for target cells (data not 
shown). When the CTL activity was checked 
against DCs pulsed with SLA containing 
gp63 protein, the effectors were still able to 
recognize and kill the targets showing that 
DCs successfully processed the gp63. In vi-
tro re-stimulation with SLA had a crucial 
role in inducing CTL activity as splenocytes 
from mice immunized with  L. mexicana 
cDNA or DC’s transfected with L. mexicana 
gp63 cDNA without in vitro re-stimulation 
did not generate CTL activity, indicating the 
importance of boosting vaccination in 
Leishmania  immunization. In this animal 
model, T cells derived from non-immunized, 
infected mice did not have significant CTL Iranian J Parasitol: Vol. 6, No.4, 2011, pp.60-75 
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activity confirming that the CTL activity 
was induced by the DNA immunization not 
the infection, contrasting with results ob-
tained in human studies (23, 26). Lack of 
CTL activity in  Leishmania  infected 
BALB/c mice might be a reason for the sus-
ceptibility of these mice to the parasites, 
which requires further investigation. The 
CTL activity induced by the DNA 
immunisation was detectable after four 
months of immunization and was similar to 
what has been reported from human patients 
with mucosal and cutaneous leishmaniasis 
before and after cure (26). 
CTL activity was also detected in mice 
immunized with SLA+IFA and DCs loaded 
with SLA. The mice showed a high level of 
CTL activity against DCs loaded with SLA. 
The CTL activity induced by SLA was much 
higher than that of mice immunized with L. 
mexicana gp63 cDNA indicating the pres-
ence of other immunogenic proteins in the 
SLA.  
 
Antibody responses to Leishmania vaccines 
It has been shown that the immunity to 
Leishmania is mainly based upon the induc-
tion of a Th1-type immune response. There-
fore, the type of the immune response in-
duced by the vaccine has a direct association 
to generating resistance to the parasite (27, 
28). It is thought that the different parame-
ters including the nature of antigen, the adju-
vant and the method of immunization affect 
the direction of immune system toward Th1 
or Th2 (29, 30).  
In the present study we sought to define the 
type of the immune response induced by a 
single antigen “ L. mexicana gp63” or a 
cocktail of antigens “ L. mexicana soluble 
antigens” using different methods of 
immunization. The type of immune response 
was determined by establishing the level of 
IgG2a and IgG1 antibody subtypes in the 
blood serum that represent the Th1 or Th2-
type immune response respectively. 
L. mexicana gp63 cDNA was administered 
by gene gun using gold. There are studies 
demonstrating that application of gene gun 
using gold particles bombardment recruits 
inflammatory cells and leads to Th2 immune 
response (29, 31). It has also been shown 
that application of adjuvant such as IL-12 or 
CpG motif as Th1 immune response enhan-
cers in DNA vaccination (29, 32), shift the 
gene-gun-mediated DNA immune response 
from Th2 towards Th1 (33). Some studies 
indicated that the Th2 induction of gene gun 
is not due to the decreased amount of DNA 
used in gene gun immunization (34) but the 
nature of the antigen strongly influences 
whether a Th1 or Th2 immune response is 
induced (35).  
 In the present studies, the results obtained 
from the gene gun immunization was in con-
trast with the previous studies (29), where 
they suggested a Th2 inducing role for gene 
gun immunization. Mice administered with 
1µg of the DNA by gene gun in BALB/c 
mice induced a sharp rise of IgG2a, which 
was detected one week after immunization. 
The level of IgG1was quite low for two 
weeks and slightly increased afterward. 
Administration of SLA with IFA induced a 
high level of IgG1 and less IgG2a, however, 
both antibodies increased during the course 
of the experiments. The kinetic responses of 
the antibody isotypes in the blood serum re-
vealed mixed Th1/Th2 immune responses, 
which might be due to the presence of sev-
eral immunogenic antigens in the SLA. The 
effect of IFA in directing the immune re-
sponse towards Th1 or Th2 was not deter-
mined in the study. DC-based vaccine po-
tency in producing antibodies has already 
been shown in HIV vaccine studies (24). 
Application of DCs loaded with SLA re-
sulted in similar profile of IgG2a and IgG1 
isotype antibodies to that induced by SLA. 
Levels of antibodies in control groups in-
jected with DCs alone or PBS could be due 
to the cross reactivity of natural antibodies, Rezvan  et al. : Leishmania mexicana Gp63 cDNA … 
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which detected by the secondary antibody in 
ELISA; the presence of natural antibodies 
cross reacting with Leishmania parasites was 
already reported in pigs, rats, mice, 
hamsters, gerbils and humans (36, 37). 
In conclusion, gene gun immunization using 
Leishmania mexicana gp63 cDNA rendered 
higher immunity to the parasite compared to 
the SLA either by intramuscular injection or 
loaded on DCs. However, the role of DCs in 
induction of immunity against  Leishmania 
needs to be more investigated. These results 
open a new approach for vaccination against 
Leishmania infection and/or other intracellu-
lar infectious agents. 
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